Publisher
Springer Science and Business Media LLC
Subject
General Economics, Econometrics and Finance,Finance,General Medicine,Health (social science)
Reference8 articles.
1. Caves, Richard E., Michael D. Whinston and Mark A. Hurwitz. (1991). Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry. Brookings Papers on Economic Activity: Microeconomics 1991, 1–66.
2. Danzon, Patricia M. and Li-wei Chao. (2000). “Does Regulation Drive out Competition in Pharmaceutical Markets?” Journal of Law and Economics XLIII, 311–357.
3. Danzon, Patricia M., Y. Richard Wang and Liang Wang. (2003). “The Impact of Price Regulation on the Launch Delay of New Drugs: Evidence from Twenty-Five Major Markets in the 1990s.” NBER Working Paper No. w9874, July 2003. Available at http://www.nber.org.
4. Frank, Richard G. and David S. Salkever. (1997). “Generic Entry and the Pricing of Pharmaceuticals.” Journal of Economics and Management Strategy 6(1), 75–90.
5. Grabowski, Henry G. and John M. Vernon. (1992). “Brand Loyalty, Entry, and Price Competition in Pharmaceuticals After the 1984 drug act.” Journal of Law and Economics XXXV, 331–350.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献